The priming effect of extracellular UTP on human neutrophils: Role of calcium released from thapsigargin-sensitive intracellular stores

Purinergic Signalling

Volumn 1, Issue 4, 2005, Pages 359-368

  Tuluc, Florin ^a   Bredetean, Ovidiu ^a   Brailoiu, Eugen ^a   Meshki, John ^a   Garcia, Analia ^a   Dun, Nae J ^a   Kunapuli, Satya P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Mitogen activated protein kinases; Neutrophil; P2Y receptors; Reactive oxygen species

Indexed keywords

EID: 29644433257     PISSN: 15739538     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11302-005-0039-8     Document Type: Article

References (46)

1. Lazarowski ER, Boucher RC, Harden, TK. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 2003; 64: 785-95. 10.1124/ mol.64.4.785
2. Bankston LA, Guidotti G. Characterization of ATP transport into chromaffin granule ghosts. Synergy of ATP and serotonin accumulation in chromaffin granule ghosts. J Biol Chem 1996; 271: 17132-8. 8663306
3. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 2002; 22: 364-73. 11884276
4. Lazarowski ER, Harden TK. Quantitation of extracellular UTP using a sensitive enzymatic assay. Br J Pharmacol 1999; 127: 1272-8. 10.1038/ sj.bjp.0702654
5. Eltzschig HK, Ibla JC, Furuta GT et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: Role of ectonucleotidases and adenosine A2B receptors. J Exp Med 2003; 198: 783-96. 10.1084/jem.20030891
6. Beukers MW, Pirovano IM, van Weert A et al. Characterization of ecto-ATPase on human blood cells. A physiological role in platelet aggregation? Biochem Pharmacol 1993; 46: 1959-66. 10.1016/ 0006-2952(93)90637-C
7. - generation. Lab Invest 1988; 58: 448-53. 2833660
8. Seifert R, Wenzel K, Eckstein F, Schultz G. Purine and pyrimidine nucleotides potentiate activation of NADPH oxidase and degranulation by chemotactic peptides and induce aggregation of human neutrophils via G proteins. Eur J Biochem 1989; 181: 277-85. 10.1111/ j.1432-1033.1989.tb14722.x
9. Yaffe MB, Xu J, Burke PA et al. Priming of the neutrophil respiratory burst is species-dependent and involves MAP kinase activation. Surgery 1999; 126: 248-54. 10.1067/msy.1999.98747
10. Meshki J, Tuluc F, Bredetean O et al. Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: Role for the P2Y 2 receptor. Am J Physiol Cell Physiol 2004; 286: C264-71. 10.1152/ajpcell.00287.2003
11. Walker BA, Hagenlocker BE, Douglas VK et al. Nucleotide responses of human neutrophils. Lab Invest 1991; 64: 105-12. 1846654
12. Tuluc F, Meshki J, Kunapuli SP. Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils. Int Immunopharmacol 2003; 3: 1775-90. 10.1016/ j.intimp.2003.08.002
13. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50. 3838314
14. Granfeldt D, Dahlgren C. An intact cytoskeleton is required for prolonged respiratory burst activity during neutrophil phagocytosis. Inflammation 2001; 25: 165-9. 10.1023/A:1011084330283
15. Janssens R, Paindavoine P, Parmentier M, Boeynaems JM. Human P2Y2 receptor polymorphism: Identification and pharmacological characterization of two allelic variants. Br J Pharmacol 1999; 127: 709-16. 10.1038/sj.bjp.0702619
16. Payne DM, Rossomando AJ, Martino P et al. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). Embo J 1991; 10: 885-92. 1849075
17. Raingeaud J, Gupta S, Rogers JS et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270: 7420-6. 7535770
18. Young PR, McLaughlin MM, Kumar S et al. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem 1997; 272: 12116-21. 10.1074/jbc.272.18.12116
19. Clerk A, Sugden PH. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett 1998; 426: 93-6. 10.1016/S0014-5793(98)00324-X
20. Favata MF, Horiuchi KY, Manos EJ et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998; 273: 18623-32. 10.1074/jbc.273.29.18623
21. Coxon PY, Rane MJ, Uriarte S et al. MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils. Cell Signal 2003; 15: 993-1001. 10.1016/ S0898-6568(03)00074-3
22. Kim C, Dinauer MC. Rac2 is an essential regulator of neutrophil nicotinamide adenine dinucleotide phosphate oxidase activation in response to specific signaling pathways. J Immunol 2001; 166: 1223-32. 11145705
23. Lal AS, Clifton AD, Rouse J et al. Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2/p38. Biochem Biophys Res Commun 1999; 259: 465-70. 10.1006/bbrc.1999.0759
24. Zu YL, Qi J, Gilchrist A et al. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. J Immunol 1998; 160: 1982-9. 9469462
25. Seifert R, Burde R, Schultz G. Activation of NADPH oxidase by purine and pyrimidine nucleotides involves G proteins and is potentiated by chemotactic peptides. Biochem J 1989; 259: 813-9. 2543370
26. Garrad RC, Otero MA, Erb L et al. Structural basis of agonist-induced desensitization and sequestration of the P2Y2 nucleotide receptor. Consequences of truncation of the C terminus. J Biol Chem 1998; 273: 29437-44. 10.1074/jbc.273.45.29437
27. Otero M, Garrad RC, Velazquez B et al. Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y2 nucleotide receptor. Mol Cell Biochem 2000; 205: 115-23. 10.1023/A:1007018001735
28. Tomhave ED, Richardson RM, Didsbury JR et al. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. J Immunol 1994; 153: 3267-75. 8089498
29. Didsbury JR, Uhing RJ, Tomhave E et al. Receptor class desensitization of leukocyte chemoattractant receptors. Proc Natl Acad Sci USA 1991; 88: 11564-8. 1763071
30. Richardson RM, Ali H, Tomhave ED et al. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity. J Biol Chem 1995; 270: 27829-33. 10.1074/jbc.270.28.16871
31. Ali H, Richardson RM, Haribabu B, Snyderman R. Chemoattractant receptor cross-desensitization. J Biol Chem 1999; 274: 6027-30. 10037679
32. Kok JW, Babia T, Filipeanu CM et al. PDMP blocks brefeldin A-induced retrograde membrane transport from golgi to ER: Evidence for involvement of calcium homeostasis and dissociation from sphingolipid metabolism. J Cell Biol 1998; 142: 25-38. 10.1083/jcb.142.1.25
33. Geiszt M, Szeberenyi JB, Kaldi K, Ligeti E. Role of different Ca2+ sources in the superoxide production of human neutrophil granulocytes. Free Radic Biol Med 1999; 26: 1092-9. 10.1016/S0891-5849(98)00283-4
34. Zhang Y, Palmblad J, Fredholm BB. Biphasic effect of ATP on neutrophil functions mediated by P2U and adenosine A2A receptors. Biochem Pharmacol 1996; 51: 957-65. 10.1016/0006-2952(95)02403-4
35. Sneddon P, Westfall TD, Todorov LD et al. Modulation of purinergic neurotransmission. Prog Brain Res 1999; 120: 11-20. 10550984
36. Birk AV, Broekman MJ, Gladek EM et al. Role of extracellular ATP metabolism in regulation of platelet reactivity. J Lab Clin Med 2002; 140: 166-75. 10.1067/mlc.2002.126719
37. Nicholas RA, Lazarowski ER, Watt WC et al. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors. J Auton Pharmacol 1996; 16: 319-23. 9131407
38. Nicholas RA, Watt WC, Lazarowski ER et al. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: Identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol Pharmacol 1996; 50: 224-9. 8700127
39. Fredholm BB. Purines and neutrophil leukocytes. Gen Pharmacol 1997; 28: 345-50. 9068971
40. Niggli V. Signaling to migration in neutrophils: Importance of localized pathways. Int J Biochem Cell Biol 2003; 35: 1619-38. 10.1016/ S1357-2725(03)00144-4
41. Li Z, Jiang H, Xie W et al. Roles of PLC-2 and -3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 2000; 287: 1046-9. 10669417
42. 2+ stores: Critical role for nicotinic acid-adenine dinucleotide phosphate (NAADP). Biochem J 2003; 373: 313-8. 10.1042/BJ20030472
43. Treiman M, Caspersen C, Christensen SB. A tool coming of age: Thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases. Trends Pharmacol Sci 1998; 19: 131-5. 10.1016/ S0165-6147(98)01184-5
44. 2+ store, with functional properties distinct from those of the endoplasmic reticulum. Embo J 1998; 17: 5298-308. 10.1093/emboj/17.18.5298
45. Filipeanu CM, Brailoiu E, Costuleanu M et al. Vasorelaxant properties of brefeldin A in rat aorta. Eur J Pharmacol 1997; 332: 71-6. 10.1016/ S0014-2999(97)01070-4
46. Mathison RD, Befus AD, Davison JS, Woodman RC. Modulation of neutrophil function by the tripeptide feG. BMC Immunol 2003; 4: 3. 10.1186/ 1471-2172-4-3